与相关的SCN2A (NaV1.2) 变体表现出多样化和复杂的功能性质
Christopher H Thompson1, Franck Potet1, Tatiana V Abramova1
1Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
The Journal of general physiology
|August 14, 2023
概括
与神经发育障碍相关的致病性SCN2A变体显示出复杂的功能变化. 自动补丁记录显示,这些变体往往具有混合的增益和功能损失效应,挑战了简单的分类.
科学领域:
- 神经遗传学 神经遗传学
- 离子通道生理学 离子通道生理学
- 发育神经科学的发展神经科学.
背景情况:
- 电压通基因中的致病变体,特别是SCN2A (编码NaV1.2),经常与神经发育障碍有关,包括,自闭症谱系障碍 (ASD) 和智力障碍 (ID).
- 一个普遍存在的模型建议二分法,即功能增益变异导致,功能丧失变异导致ASD/ID,但这基于有限的,异质的数据.
- 大多数与疾病相关的SCN2A变异的功能后果仍然没有特征,需要标准化,高通量方法进行全面分析.
研究的目的:
- 验证自动补丁记录作为一种高通量方法,用于在统一条件下评估SCN2A变体的功能.
- 为了调查变体功能障碍的二进制分类 (增益与功能丧失) 是否适用于更大的SCN2A变体队列.
- 探索与神经发育障碍相关的NaV1.2变体的复杂功能性质.
主要方法:
- 利用自动化补丁电生理学来记录28种与疾病相关的和4种常见的SCN2A变异的功能性质.
- 在HEK293T细胞中表达了NaV1.2的两个替代拼接异型,用于变体分析.
- 将自动化补丁发现与先前发布的手动补丁数据进行了比较,以验证.
主要成果:
- 自动化补丁记录被证明是一个有效和高通量方法,产生与之前手动补丁研究一致的结果.
- 许多相关的SCN2A变体显示了复杂的功能配置文件,表现出既有功能的增益和丧失特征,这些特征挑战了简单的二进制分类.
- 该研究证明了在标准化条件下分析更多变体的可行性,提高了实验严谨性和减少了操作者偏见.
结论:
- SCN2A变种的功能后果比以前假设的要复杂得多,通常呈现混合的功能增益和功能丧失表型.
- 自动补丁电生理学是一种强大的和可扩展的方法,用于详细的功能注释离子通道变体.
- 这种方法有助于更细致地了解与SCN2A功能障碍相关的神经发育障碍中的基因型-表型相关性.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.8K
04:41Author Spotlight: Insights into the Techniques and Findings of Recent Advancements in Epilepsy Research
Published on: October 13, 2023
1.6K
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
346
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
346
02:26Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
01:13Seizures: Classification
413
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
413
01:24Arteries of the Lower Limbs
214
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
214
01:26Voltage-gated Ion Channels
8.3K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.3K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
461
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
461